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ABSTRACT
Introduction Early infant diagnosis (EID) of HIV and
timely initiation of antiretroviral therapy can significantly
reduce morbidity and mortality among HIV-positive
infants. Access to EID is limited in many low-income
and middle-income settings, particularly those in which
standard care involves dried blood spots (DBS) sent to
centralised laboratories, such as in Papua New Guinea
(PNG). We conducted a qualitative exploration of the
feasibility and acceptability of implementing a point-of-
care (POC) EID test (Xpert HIV-1 Qualitative assay) among
health workers and key stakeholders working within the
prevention of mother-to-child transmission of HIV (PMTCT)
programme in PNG.
Methods This qualitative substudy was conducted as part
of a pragmatic trial to investigate the effectiveness of the
Xpert HIV-1 Qualitative test for EID in PNG and Myanmar.
Semistructured interviews were undertaken with 5 health
workers and 13 key informants to explore current services,
experiences of EID testing, perspectives on the Xpert
test and the feasibility of integrating and scaling up POC
EID in PNG. Coding was undertaken using inductive and
deductive approaches, drawing on existing acceptability
and feasibility frameworks.
Results Health workers and key informants (N=18) felt
EID at POC was feasible to implement and beneficial
to HIV-exposed infants and their families, staff and the
PMTCT programme more broadly. All study participants
highlighted starting HIV-positive infants on treatment
immediately as the main advantage of POC EID compared
with standard care DBS testing. Health workers identified
insufficient resources to follow up infants and caregivers
and space constraints in hospitals as barriers to
implementation. Participants emphasised the importance
of adequate human resources, ongoing training and
support, appropriate coordination and a sustainable supply
of consumables to ensure effective scale-up of the test
throughout PNG.
Conclusions Implementation of POC EID in a low HIV
prevalence setting such as PNG is likely to be both

Strengths and limitations of this study
►► Qualitative explorations of the feasibility and accept-

ability of new healthcare interventions can provide
valuable information on barriers and enablers to
implementation.
►► This is the first study to explore the feasibility and
acceptability of implementing a point-of-care early
infant diagnostic test in a low HIV prevalence country in the Asia-Pacific region.We interviewed health
workers and key staff within Papua New Guinea’s
HIV programme to explore their perspectives on the
factors associated with successful implementation
of the test within the context of a research project.
►► The study was implemented in two clinics in the
Highlands of Papua New Guinea and may, therefore,
not be generalisable to other provinces or other
countries in the region.

feasible and beneficial with careful planning and adequate
resources.
Trial registration number 12616000734460.

INTRODUCTION
Over 180 000 children aged less than 15
years are newly infected with HIV worldwide every year; the vast majority through
perinatal transmission.1 HIV in children
progresses more rapidly than in adults, with
up to 50% mortality in the first 2 years of
life in the absence of antiretroviral therapy
(ART).2 3 Early infant diagnosis of HIV (EID)
and timely ART initiation can significantly
reduce morbidity and mortality among HIV-
positive newborns and infants.3 In most
resource-constrained settings, EID testing is
based on heel prick dried blood spot (DBS)
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studies have investigated the acceptability and feasibility
of various POC tests including CD4 T cell tests and HIV
rapid tests,23–25 qualitative evidence on the feasibility and
acceptability of implementing POC EID testing is lacking
in both low prevalence settings and the Asia-
Pacific
region.
This paper evaluates the feasibility and acceptability of
implementing the Xpert HIV-1 Qualitative test for EID in
PNG, and explores the potential for scale-up throughout
the country.

METHODS
This feasibility and acceptability assessment is one component of a cluster-randomised controlled stepped wedge
trial of the effectiveness of the Xpert HIV-1 Qualitative
test for EID on HIV-exposed infants in PNG and Myanmar.
The overall study was undertaken in two hospitals in PNG,
using both quantitative and qualitative methods.
Patient and public involvement statement
Patients and the public were not directly involved in
the design, conduct, reporting or dissemination of the
research. The results of the cluster-randomised trial and
the qualitative substudies will be disseminated to local
communities through workshops and written summaries
of findings.
Study setting
PNG is the largest and most populated of the Pacific
Island countries.13 The health system faces a number
of challenges including funding constraints, significant
shortages of health workers, inconsistent availability of
basic medication and supplies, and inadequately maintained health facilities.12 26 27 It is within this context that
PNG’s PMTCT programme operates and in which this
field trial was undertaken in two provincial hospitals:
Mount Hagen Hospital (Western Highlands Province)
and Goroka Base Hospital (Eastern Highlands Province).
These public hospitals were chosen due to the relatively
high number of pregnant women with HIV undergoing
care and treatment at respective PMTCT clinics.
Overview of field trial
The field trial was implemented over 14 months with
6 months of follow-up of enrolled participants. Both study
sites started in the control phase and moved into the intervention phase at different (randomly assigned) time points,
following a transition month. During transition prior to
the intervention phase, the GeneXpert platform was introduced into the facility and research nurses and other healthcare staff were trained on the technology. The machines
were kept in the same room where patient consultations
occurred and were primarily run by the research nurses.
Standard care DBS testing was still undertaken during
the intervention phase, and caregivers of enrolled infants
were provided with both Xpert test and DBS results as they
became available. The result of the Xpert test was used for
Mohamed Y, et al. BMJ Open 2020;10:e043679. doi:10.1136/bmjopen-2020-043679

BMJ Open: first published as 10.1136/bmjopen-2020-043679 on 19 November 2020. Downloaded from http://bmjopen.bmj.com/ on May 5, 2021 by guest. Protected by copyright.

samples being sent to central laboratories for virological testing using specialised laboratory equipment and
highly trained personnel.4 This necessitates caregivers
making a return visit to the clinics to receive test results,
and may require multiple visits when results are not yet
available. A review of EID in resource-constrained settings
found significant disparities in the proportion of DBS test
results returned to caregivers, with a range of 37%–90%,
and with the time to results communication ranging from
9 days to 21 weeks.5 It is estimated that only half of all HIV-
exposed infants in low-income and middle-income countries receive an HIV test result within 2 months of birth
as recommended by WHO guidelines.6 Improvements
in testing rates and reductions in turnaround times are
crucial for reducing adverse outcomes for HIV-exposed
infants.
With an estimated HIV prevalence of 0.8% in the adult
population (15–49 years), Papua New Guinea (PNG)
has the highest HIV prevalence in the Pacific region.7–9
The PNG national HIV policy recommends HIV-exposed
infants be tested at 6 weeks of age using DBS that are sent
to the centralised laboratory in the capital, Port Moresby,
for analysis.10 According to UNAIDS data, 79% of pregnant women living with HIV receive antiretroviral medication for the prevention of mother-to-child transmission
(PMTCT), and three-quarters of infants (75%) are tested
for HIV within 2 months of birth.9 PNG has limited transport and telecommunications infrastructure, very diverse
geography and a predominantly rural population.11–13
These factors contribute to logistical challenges with
the transportation of DBS samples and communication
of results leading to significant delays in the return of
results to the clinic, to families and, where indicated, ART
initiation.
According to WHO, a point-of-care (POC) test should be
easy to use, accurate, affordable, equipment-free, robust,
deliverable to end users and provide rapid results—ideally
within 30 min.14 One of the main benefits of POC testing
is the availability of results and treatment during the same
visit to a healthcare facility.15 Despite taking 90 min to
run, the Xpert HIV-1 Qualitative assay (Cepheid, Sunnyvale, California, USA) is widely considered to be a POC
test given its ability to provide results on the same day as
testing.16 The molecular Xpert HIV-1 Qualitative test has
proven to perform well both in the laboratory and in-field
evaluations in high prevalence settings.17–19 A recent
observational study in eight African countries found that
POC EID testing, including the Xpert HIV-1 Qualitative
assay, significantly reduced the time to HIV test results
communication and enabled earlier initiation of ART.20
However, the availability of a POC test does not always
translate to its widespread uptake. A number of factors
can hinder the effective implementation of these technologies such as policies, user perspectives and health
system constraints, including cost.21 Examining the feasibility and acceptability of implementing a new healthcare
intervention is one way to identify these barriers early and
put strategies in place to address them.22 While numerous
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Qualitative data collection
Towards the end of field implementation, participants for
this qualitative component were recruited from the two
study sites in Goroka and Mt. Hagen as well as from the
national capital Port Mores by, where the National Department of Health, Central Public Health Laboratory (CPHL)
and other key non-government organisations (NGOs) are
located. Interviews with health workers were undertaken
either in the hospitals themselves or in a private office in the
PNG Institute of Medical Research, adjacent to the clinic.
With consent, key informant interviews took place in the
offices of interviewees or appropriate rooms within their
respective organisations in Port Moresby, Mt. Hagen or
Goroka. The locations of all interviews ensured privacy and
confidentiality were maintained. Qualitative data collection
took place from January to April 2018, when both study
sites were in their last months of field implementation.
Study participants
Five nurses across both sites were purposively recruited
for in-depth interviews. This included one research nurse
from each of the two sites who were responsible for study
implementation, and three nurses working within PMTCT
services at participating hospitals. Research nurses were
hired specifically for this field trial and were employed at
the PNG Institute of Medical Research and seconded to the
respective clinics prior to implementation. Both research
nurses had previously worked at their respective hospital,
were familiar with the setting and the staff and were well
trained in clinical care. In addition, 13 key informants
were recruited: senior staff within the PMTCT programme
in Goroka (n=1), Mt. Hagen (n=2) and Port Moresby
(n=2); staff from CPHL where standard care EID testing
is performed (n=2); national government representatives
(n=3) and staff from international and local NGOs (n=3).
The international NGO is involved in providing technical
support and policy advice regarding health in PNG and
globally; whereas the local NGO provides community-led
support and advocacy for people living with HIV in PNG.
Local study investigators purposively identified key informants to maximise representation across the PMTCT
programme within PNG. An additional two key informants
from Port Moresby were contacted and asked to take part in
the study, however responses were not received.
Research team
The first author (YM) drafted the semistructured interview guides with comprehensive revision and modification
by the senior author (AK-H) prior to finalisation. Interviews were undertaken by an experienced postgraduate
female social scientist from the PNG Institute of Medical
Mohamed Y, et al. BMJ Open 2020;10:e043679. doi:10.1136/bmjopen-2020-043679

Research (MK), and who had no previous involvement in
the implementation of the main study.
Design
Semistructured interviews with health workers explored
current PMTCT services, experiences of standard care
EID based on centralised DBS testing, involvement in
study implementation including experiences with and
perspectives on the Xpert HIV-1 Qualitative test for EID,
acceptability of same-day HIV results, and the feasibility of
integrating the test into routine clinical care. Interviews
with key informants focused on their experiences with
study implementation where applicable, the scope and
quality of the current PMTCT programme, the perceived
impact of POC EID on health services, and the feasibility
of test scale-up throughout PNG.
A total of 18 interviews were conducted with the
majority lasting between 30 and 90 min. Interviews were
conducted either in English or Tok Pisin (both national
languages in PNG), depending on the preference of the
interviewee, and were digitally recorded with participants’ consent.
Data analysis
All interviews were transcribed verbatim and, where necessary, translated into English. Each transcript was carefully reviewed by the interviewer to ensure the accuracy
and consistency of transcription and translation. Transcripts were coded using both an inductive and deductive
approach with NVivo V.11 qualitative data analysis Software (QSR International). The first author developed a
coding framework following an initial reading of the data
and using existing acceptability and feasibility frameworks
from the published literature.22 28 29 Following verification
of the coding framework by the qualitative researcher who
collected the data and the senior author, the first author
systematically coded each transcript and analysed the data
according to the frequency and content of codes and
themes.
Ethical considerations
Written informed consent was obtained from each
participant, and all interviews were digitally recorded
with written consent from interviewees. All identifiable
information was removed, and no names used to identify study participants. Electronic transcripts were stored
on password-
protected computers accessible only to
members of the research team involved in the analysis.

RESULTS
Participant characteristics
A total of 18 participants were included in this qualitative inquiry—5 health workers and 13 key informants.
An overview of study participants is presented in table 1.
Both research nurses and most of the clinical staff were
based at the study sites in Mt. Hagen and Goroka, while
the majority of key informants involved in HIV policy and
3
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clinical decision making. Due to the stepped-wedge design
of the study, Mt. Hagen implemented the intervention for 9
months and Goroka for 4 months. As part of the trial, qualitative data were collected from both caregivers with infants
enrolled in the study (results presented elsewhere) as well
as from health workers and key informants.
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No of participants by location (sex)
Organisation

Position type

Mt. Hagen

Goroka

Healthcare workers
 PNG Institute of Medical Research

Research nurse

 
1 (F)

1 (F)

 Provincial Hospitals

Clinical nurse

1 (F)

2 (F)

 Subtotal

2

3

Key informants

 

 Provincial Hospitals

Clinical

1 (F)

Laboratory

1 (M)

Programmatic
 Port Moresby General Hospital

Port Moresby

Total

5

1 (M)

Clinical

1 (F)

Programmatic and clinical

1 (F)

 Central Public Health Laboratory

Laboratory

 National Department of Health

Programmatic and clinical

2 (M)

 National AIDS Council Secretariat

Programmatic and policy

1 (M)

 WHO

Programmatic and policy

1 (M)

 Local NGO

Community representative

2 (F, M)

Subtotal
Total

1 (F)

3
5

1 (M)

1
4

9
9

13
18

F, female; M, male; NGO, non-government organisation; PNG, Papua New Guinea.

programming were based in Port Moresby. All five healthcare workers interviewed were female, and 7 of 13 key
informants were male.
The main themes identified included challenges with
current EID services and the consequent need for POC
EID testing; the perceived impact of POC EID on quality
of care for infants and caregivers, and the potential benefits for the PMTCT programme more broadly; barriers
and facilitators to integration of the Xpert test into
routine clinical care, including factors to be considered
prior to scale-up of POC EID throughout the country.
Acceptability of POC EID testing
Perceived need for POC EID
POC EID testing was seen by both health workers and key
informants as a potential way to overcome the existing
challenges within the current EID programme. Health
workers, laboratory staff and policy-
makers in all sites
noted the long turnaround time between DBS collection from HIV-exposed infants and the communication
of results to facilities and families. Reasons for this delay
included the absence of a current National Department
of Health PMTCT programme coordinator since the
previous year; the availability of only one Roche Amplicor
HIV-1 Qualitative DNA assay for virological testing (V.1.5;
Roche Molecular Systems, Branchburg, New Jersey,
USA) in Port Moresby for testing samples for the entire
country; the limited number of laboratory staff employed
to run the machine for EID testing; and the lack of consistently available government funds to maintain testing.
4

Inadequate communication channels between hospital
and laboratory services also contributed to the delay in
the return of results, with health workers describing telephoning and emailing CPHL but being unable to get
through to the appropriate department, sometimes due
to network failures. The lack of clear, consistent guidelines for results communication between the hospitals
and CPHL further exacerbated delays and increased the
perceived need for a POC EID.
Health workers and key informants described how, in
some cases turnaround times of several months for EID
results prevented HIV-infected infants from commencing
ART in a timely manner. This was acknowledged as having
profound implications for the health of HIV-
exposed
infants as well as the emotional well-being of caregivers.
We lose a lot of cases (…) where we are sending samples to CPHL, and they wait for 6 months and sometimes they (infants) die. (Key informant, laboratory,
Mt. Hagen)
…they (HIV-infected women) don’t want their children to become infected. So having to wait for that
period, finding out whether (their baby is) positive or
negative is very traumatizing. (Key informant, community, Port Moresby)
The delay in receiving infants’ HIV results from the
central laboratory was particularly challenging for health
workers. Clinical staff described feeling ‘frustrated’,
Mohamed Y, et al. BMJ Open 2020;10:e043679. doi:10.1136/bmjopen-2020-043679
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Table 1 Overview of study participants by organisation, position type, location and sex

Open access

…when the same mother comes back I usually feel
ashamed to talk (…). It is my job too so I would give
excuses that the machine in Moresby is probably damaged or we didn’t receive the email and they didn’t
send back (the results), and man, I would get cross
for no good reason on here in front of the mothers.
(Clinical nurse, Mt. Hagen)
These feelings negatively impacted on job satisfaction
and reduced the perceived quality of care that could
be provided. Some caregivers, they shared, would stop
returning altogether if results were extensively delayed.
Perceived impact of POC EID on quality of care
Being able to commence HIV-infected infants on ART
‘straight away’ was identified by all study participants as
the main advantage of POC EID testing, reducing the
likelihood of child morbidity and mortality.
…we saved four babies with the result of the
(GeneXpert) machine. They are tolerating (ART) really well. (Research nurse, Mt. Hagen)
Another benefit of POC EID testing was a sense of job
satisfaction at providing good quality care to caregivers
and babies.
For the mothers, they need to hear the results sooner, and we also want to hear the results sooner also
for our jobs, we will feel motivated to work. (Clinical
nurse, Mt. Hagen)
Research nurses reported a reduction in lost to
follow-up of HIV-exposed infants and their caregivers due
to the provision of same-day results. Hospital staff in the
study sites stated that more caregivers were coming to
the clinics for EID testing as a result of the availability of
same-day results than would normally be expected with
standard EID testing. Health workers felt that caregivers
were more motivated to return to the clinic for appointments in order to find out if their child or children had
HIV, and that the majority were willing to wait for 90 min
to receive HIV test results.
She (mother) doesn’t want the baby to be infected
like herself, so she made her time available, and she
came on time. (Research nurse, Goroka)
Health workers acknowledged that not all caregivers
were able to wait for 90 min, in addition to the time for
sample collection and preparation. POC testing was not
able to address competing priorities that made it difficult for caregivers to stay at the clinic. For example, the
research nurse in Mt. Hagen reported that one mother
of twins was unable to wait for the test results because her
husband ‘chased her away’ from the clinic. Both twins
were found to be HIV-positive, and while staff made every
effort to contact the family, it was not until after one twin
had died that the family returned to the health facility.
Mohamed Y, et al. BMJ Open 2020;10:e043679. doi:10.1136/bmjopen-2020-043679

The research nurse in Mt. Hagen highlighted potential risks associated with same-day results for HIV-exposed
infants. Having received an HIV-negative test result for
their child, some mothers may want to stop any ongoing
HIV exposure for the infant by discontinuing breast
feeding, despite breast feeding being recommended in
national and international guidelines.10 30 This risk was
heightened in infants receiving same-day results who are
likely to be much younger than those using the standard
care DBS test.
…sometimes when they hear this result, when the
baby is negative, they quickly want to put the baby
on Lactogen (formula) because they know that, their
baby is negative so they don’t want to breast feed anymore. (Research nurse, Mt Hagen)
Another perceived risk was that mothers presenting
for their infant’s first EID test might not understand that
further testing would still be required after cessation of
breast feeding to definitively confirm the HIV status of
the child, and may therefore not return to the clinic for
further HIV testing. This was less of an issue with standard
care testing as caregivers often brought their children
back to the clinic multiple times to see if standard care
results were available, whereas same-day testing reduced
the need for multiple visits. Health workers felt that good
quality counselling and provision of accurate information
to caregivers immediately after provision of POC results
could mitigate these risks.
Potential benefits for PMTCT programme
All interviewees believed the Xpert HIV-1 Qualitative test for EID would be beneficial for the PMTCT
programme and the country overall. As one key informant described it, POC EID testing would bring the
PMTCT programme to the ‘next level’. Same-day EID
results were seen as essential for improving maternal and
child health services, and substantially impacting on the
HIV epidemic in PNG.
I think we’re making progress against targets that we
are setting, the 2030 targets of, zero new infection by
2030. So, if we’re able to strengthen the PPTCT program, …the program will be matured, so that’s a success. (Key informant, programmatic, Port Moresby)
By providing same-
day results and reducing lost to
follow-up, POC EID was seen as a way to improve reporting
of paediatric HIV and enable better monitoring and evaluation of the effectiveness of the PMTCT programme in
PNG. Laboratory staff from CPHL also appreciated the
benefits of POC EID testing in health facilities, particularly in terms of reducing the strain on overburdened
central laboratory services responsible for EID testing
throughout the entire country.
Study participants highlighted the likely impact of POC
testing on the efficiency of EID services, with benefits for
patients, staff and the health system more broadly.
5
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‘guilty’ and ‘ashamed’ at not being able to provide results
to caregivers returning to the hospitals.
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Key informants identified the importance of consistent
implementation of standard operating procedures on
all aspects of running the test as well as mechanisms for
quality control and external quality assurance. Laboratory staff in particular described the need for adequate
support, supervision and mentoring of clinical staff not
familiar with laboratory testing procedures.

Key informants at the community, programmatic and
policy levels identified the additional testing available
through the GeneXpert platform, including tuberculosis
and HIV viral load monitoring, as added benefits of the
technology. This was perceived as an important facilitator
for scale up and sustainability.

We need to train nurses (…). They need to work very
very closely with the lab persons or the experts in
there. And the other challenge is that, because it’s a
machine that is being used in the lab, we try to take it
out from the lab, put it in the clinic and my challenge
is that the quality and the results being produced because there are likely to be mistakes being added. So
there needs to be some sort of quality check on the
reports that we produce. (Key informant, laboratory,
Mt. Hagen)

Feasibility of implementing POC EID
Human resources
Research nurses were recruited by the PNG Institute of
Medical Research and colocated at both study sites to
undertake study procedures and conduct POC EID testing
during the intervention phase of the study. In some cases,
they also relayed test results to caregivers. According to
the health workers interviewed, the presence of these
additional staff made implementation feasible at the
study sites. Health workers acknowledged that without
these research nurses, it would have been challenging
to integrate POC EID into their existing workloads. This
was especially true in Mt. Hagen, where the number of
patients presenting for EID increased substantially during
the study period, with participants hypothesising that
this was due to the presence of the GeneXpert machine.
Despite acknowledging the potential for an increased
workload, the majority of health workers were willing to
spend the time conducting POC EID due to its perceived
importance for the quality of care provided.
In contrast, some health workers suggested that access
to POC EID would reduce clinic staff workload by
decreasing the amount of time spent transporting and
following up on DBS samples sent for centralised laboratory testing in Port Moresby.
This (Xpert HIV-1 Qualitative test) is making my job
much easier (…). It’s not like before where I used to
go and send the samples to CPHL. If this study goes
well, the thing (GeneXpert® machine) is already installed. I will not move around and waste my time out
at the post office or wait for the result to come back.
(Clinical nurse, Goroka)
Participants emphasised the importance of training and
hiring an appropriate number of staff in facilities where
POC EID services would be implemented. According to
health workers, training on the GeneXpert machine and
Xpert HIV-1 Qualitative test should be similar to that
provided in this study with both theoretical and practical
components, a focus on preparing the cartridges and
running the test, the availability of written guidelines
on testing procedures, and adequate supervision and
support.
6

Coordination
Key informants highlighted the need for appropriate
up of any new technology
coordination of the scale-
throughout the country. Multiple participants mentioned
the importance of the National Department of Health
taking ownership of a national programme, especially
with regard to sustainable funding and essential coordination for driving the scale-up as well as maintaining the
quality of services.
Other key informants felt that decentralising the EID
services would be more beneficial to the effectiveness of
the programme, ensuring that someone was available at
each hospital to address any unforeseen challenges.
Integration of POC EID into health services
While the majority of Xpert HIV-1 Qualitative test results
were provided on the same day, health workers described
instances of patients arriving late in the day and consequently having to return the next day for their results.
Although no longer POC testing by definition, health
workers agreed that next day results were still faster
than standard care. The clinics attempted to maximise
same-day results by prioritising caregivers bringing their
children in for EID testing and commencing these tests
immediately wherever feasible. The research nurses also
identified the ability to store infant blood samples for up
to 72 hours as an advantage of the test, making testing
easier to integrate into routine clinical care. Some health
workers also appreciated that the 90 min during which the
Xpert HIV-1 Qualitative test was running could be used to
undertake other clinical duties such as health education.
One particular challenge that the research team
faced in implementing POC EID in the two study sites
was following up caregivers who were unable to wait
for same-day results and did not return to the clinic the
following day. Caregivers were difficult to trace because
no systems were in place at either study site for follow-up,
research nurses did not have consistent access to a vehicle
Mohamed Y, et al. BMJ Open 2020;10:e043679. doi:10.1136/bmjopen-2020-043679
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I think it’s going to have a great impact in terms of
getting results within few hours and get them treated. So actually, we are saving lives. We identify in getting patients on treatment, and we are actually saving
lives; that’s impact. And I think this is a great benefit
for the patients and it’s for the country as well.
(Key informant, laboratory, Mt. Hagen)

Open access

The communication system that was another challenge that I had…Sometimes when (caregivers) give
their numbers to us, someone else is answering the
phone and not this client. They lose their phones
sometimes, and that’s another challenge about
follow-ups. (Research nurse, Mt. Hagen)
Infrastructure
Identifying an appropriate location for the GeneXpert
machine within the clinics was important for implementing POC EID testing. Both study sites have a high
patient load and limited space, and health workers highlighted the challenges of trying to fit the new technology
into the clinic.
Ensuring a sustainable and consistent supply of test
cartridges was also identified as an important aspect of
integrating POC EID testing into routine clinical care.
While both sites had sufficient numbers of cartridges
throughout the study, maintaining the supply proved
challenging at times as enrolment numbers increased
unexpectedly in Mt. Hagen. The Alere PIMA machine
was cited as an example of a technology that has not been
sustainably scaled up in PNG, with sites currently lacking
access to cartridges and therefore being unable to run
POC CD4 tests. Ensuring the sustainability of POC EID
testing was believed to require clear delegation of responsibilities for ordering cartridges and necessary supplies.
Multiple key informants identified the cost of cartridges
as a potential challenge to sustainability.
We are happy for the scaling up to go rural, especially
at the district level but the funding is a big problem
for us. Who will now buy the GeneXpert Machine?
Who will pay for the cartridges? (Key informant, programmatic, Goroka)
Maintenance of the GeneXpert machine was also identified as a potential challenge to scale-up, with key informants raising concerns about machines not being used if
they broke down due to inadequate maintenance plans.
DISCUSSION
This is the first study to explore the feasibility and acceptability of implementing a POC EID test in a low HIV prevalence, lower-middle-income Asia-Pacific country. Health
workers and key staff within the PMTCT programme
found the Xpert HIV-1 Qualitative test for EID acceptable and feasible to implement within the context of a
research project and potentially more broadly, and all
participants believed that the test would reduce time
to treatment initiation and improve the quality of care
provided to HIV-exposed infants and their families. A
nurse-led model of care combined with the presence of
research nurses at the two study sites enabled immediate
initiation of ART for infants found to be HIV-infected
Mohamed Y, et al. BMJ Open 2020;10:e043679. doi:10.1136/bmjopen-2020-043679

on the same day as testing. POC EID has been demonstrated to significantly reduce the time to provision of
HIV test results and enable earlier ART initiation.20 The
potential benefits of scaling up POC EID are particularly
important in a context like PNG where PMTCT services
are constrained, and preventable transmission of HIV
from mothers to their children occurs, although the cost-
effectiveness in a low prevalence setting warrants further
investigation.
According to study participants, the primary benefit
of POC EID testing is the provision of same-day results
and immediate initiation of treatment for HIV-positive
infants. Research has clearly shown the importance of
early treatment initiation for the health of HIV-exposed
infants, with an up to 76% reduction in infant mortality.2
POC EID has recently been shown to be effective in
improving the turnaround time of results and enabling
earlier ART initiation in high HIV prevalence settings.20
While our study highlights the considerable potential
of the Xpert HIV-1 Qualitative test to improve quality
of care within the EID programme in PNG, a number
of key strategies need to be in place within the PMTCT
cascade to maximise impact.5 For example, all pregnant
women must have access to HIV testing and treatment,
and mechanisms for efficient patient follow-up need to
be established.5
Health workers interviewed in this study highlighted
two potential challenges with the provision of same-day
EID results. First, obtaining an HIV result early could
conceivably impact on a caregiver’s motivation to return
to the clinic for final confirmatory testing after the
cessation of breastfeeding. It is likely, however, that the
benefits of finding out an infant’s HIV status on the
same day as testing outweigh the risks of potential lost
to follow-
up in the future, especially considering that
caregivers may become lost to follow-up within standard
EID programmes and consequently never receive a test
result for their infant. A study looking at barriers to EID
in Malawi found that one third of women living with HIV
did not return for their child’s HIV test results, primarily
due to transportation challenges.31 Promisingly, a recent
qualitative inquiry in Lesotho looking at very early diagnosis of HIV in infants found that mothers and health
workers did not believe that birth testing would impact on
the likelihood of returning to health facilities for subsequent HIV testing.32
The second identified challenge with same-day testing
was the potential cessation of breastfeeding by mothers
whose infants were found to be HIV negative. In the
context of lifelong ART for all adults living with HIV
including pregnant women, WHO recommends exclusive
breastfeeding for the first 6 months of life and continued
breast feeding up to 2 years and beyond for all infants
born to women living with HIV.33 Particularly in a setting
such as PNG with a high burden of childhood illness, early
cessation of breast feeding could have significant consequences for infant and child morbidity and mortality.34 In
addition, a qualitative study in PNG found that front-line
7
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for home visits, and many caregivers were not contactable
by mobile phone.
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Tynan et al38 also describe patient follow-up as a pervasive barrier to successful implementation of the PMTCT
programme in PNG. It is, however, worth noting that
the availability of POC EID testing is likely to reduce the
need for active tracing of mother–infant pairs for results
communication compared with standard care DBS
testing.
This study has a number of limitations that impact on
the interpretation of the findings. While the qualitative
researcher facilitating the semistructured interviews was
not part of the overall study team, she is a staff member of
one of the organisations leading the project. Therefore, it
is possible that social desirability bias could have resulted
in a tendency towards a focus on the positive aspects of
POC EID by participants. It is also possible that key informants who were contacted to take part in this qualitative inquiry but did not respond to these requests had a
different opinion to those who were interviewed. Finally,
the overall study was only implemented in two clinics in
the Highlands of PNG and may therefore not be generalisable to other provinces. Obtaining the perspectives of
key stakeholders in Port Moresby with considerable experience of the national EID programme helped to mitigate
this risk.

CONCLUSIONS
The Xpert HIV-1 Qualitative test is acceptable and
feasible to implement in a low prevalence, lower-middle-
income country setting such as PNG within a research
context and potentially more broadly, and will likely be
beneficial to the national PMTCT programme. POC
EID has the potential to reduce the time to initiation
saving treatment among HIV-
infected infants
of life-
in PNG. Ensuring the availability of sufficient human
resources, sustainable funding and effective coordination are critical for successful implementation of POC
EID in this setting.
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health workers are not aware of best practice infant
feeding guidelines within the context of HIV.35 With wider
scale-up of POC EID in PNG, monitoring the impact of
same-
day results on breastfeeding practices would be
advisable. Further promotion of exclusive breastfeeding
through individual and group counselling at antenatal
and postnatal care by both health workers and peer counsellors would likely mitigate any detrimental impact of
POC EID testing on breastfeeding rates.36
Within the context of a research project, health
workers found implementation of POC EID to be
feasible in the two study sites. The availability of additional staff members to perform the test was essential
to ensure integration of the testing procedure into
routine clinical care. Research nurses were also responsible for study-specific data collection, which would not
be required once the test was scaled up outside of the
research context. Performing the Xpert HIV-1 Qualitative test does have an impact on the workload of clinic
staff, particularly as the test is more complex and takes
longer to run than the average lateral flow POC device.
A systematic review of the acceptability and feasibility
of POC CD4 testing identified increased staff workload as an important operational challenge.24 However,
health workers involved in our project were very optimistic about the potential for integration of the test
into routine practice, and many were willing to increase
their own workload for the benefit of their patients. A
recent study in South Africa found that health workers
were willing and able to manage the additional workload
associated with POC EID testing using the Alere q 1/2
Detect device, and concluded that POC EID testing was
highly acceptable in a field setting.37 Ensuring adequate
staffing in clinics where POC EID is implemented will
be crucial for sustainability, especially within a health
system facing a chronic shortage of health workers
and considerable resource constraints, as is the case in
PNG.12 27 38
Study participants identified the importance of
adequate human resources; ongoing training and
support; a sustainable supply chain; sufficient space for
the GeneXpert machine; and effective coordination
and oversight to maximise the sustainability of POC EID
in PNG. These components are similar to those highlighted in other feasibility studies of novel healthcare
interventions, particularly in low-income and middle-
income country settings. A lack of coordination of
maternal and infant HIV services negatively impacted
on EID outcomes in a study in Malawi39 and a review of
barriers to scale up of POC technologies also identified
infrastructure, workflow, training and supply chain as
important challenges.21 Importantly, these key drivers
of sustainability have been reported by health workers
as significant challenges within the current PMTCT
programme in PNG.38
Ensuring adequate resources to follow-up patients was
identified in our study as an important component of
sustainable scale-up of the Xpert HIV-1 Qualitative test.
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